AmpliTech Group's biggest risks in the FY2024 10-K
- Substantial historical net losses and accumulated deficit threaten ongoing operations and financial stability.
- Dependence on CEO Fawad Maqbool and key technical personnel poses retention and control risks.
- Material weaknesses in internal accounting controls could lead to inaccurate financial reporting.
The risks most specific to AmpliTech Group
- Risks Relating to our Business
Our revenue, earnings, margins and other operating results have fluctuated significantly in the past and may fluctuate significantly in the future
We incurred net losses of $11,242,404 in 2024 and $2,465,439 in 2023, resulting in an accumulated deficit of $21,012,127 as of December 31, 2024.
- Risks Relating to our Business
There is no assurance that the Asset Purchase Agreement will close or that even if we close we will realize the anticipated benefits
The Asset Purchase Agreement entered into on March 26, 2025, may not close or realize anticipated benefits due to required third-party customer actions.
- Risks Relating to our Business
We have entered into non-binding letter of intent for purchase orders and there no assurance that we will enter into definitive purchase orders or generate revenues as expected
A non-binding letter of intent with a contract manufacturer for $78 million of Oran radios may not result in definitive purchase orders or expected revenues.
- Risks Relating to our Business
Our market is very competitive. If we fail to compete successfully, our business and operating results will suffer
We face intense competition in the amplifier industry from established rivals like Lucix, Erzia, and Narda-Miteq who possess greater financial and research resources.
- Risks Relating to our Business
Our business would be adversely affected by the departure of members of our executive management team
Our business relies heavily on Chairman, President and CEO Fawad Maqbool, who is not bound by an employment contract.
- Risks Relating to our Business
We have material weaknesses in our internal accounting control over financial reporting and failure to remediate a material weakness in internal accounting controls could result in material misstatements in our financial statements
We have identified material weaknesses in our internal accounting controls relating to a lack of segregation of duties and ineffective financial statement disclosure controls.
- Risks Relating to our Common Stock and our Listed Warrants
Because Fawad Maqbool, our Chairman controls a significant number of shares of our voting capital stock, he has the ability to influence actions requiring stockholder approval
Chairman and CEO Fawad Maqbool holds 14% of our voting capital stock, allowing him to significantly influence matters submitted to stockholders.
- Risks Relating to our Common Stock and our Listed Warrants
There can be no assurance that we will be able to comply with the continued listing standards of the Nasdaq Capital Market, a failure which could result in the de-listing of our common stock
Failure to meet Nasdaq continued listing requirements, such as minimum bid price and financial standards, could result in the de-listing of our common stock.
All 38 risk factors
Headings as the filing states them, in filing order.
Risks Relating to our Business
- 01Our revenue, earnings, margins and other operating results have fluctuated significantly in the past and may fluctuate significantly in the future
- 02There is no assurance that the Asset Purchase Agreement will close or that even if we close we will realize the anticipated benefits
- 03We have entered into non-binding letter of intent for purchase orders and there no assurance that we will enter into definitive purchase orders or generate revenues as expected
- 04The Company is dependent on the global supply chain and has in the past experienced supply chain constraints, as well as increased costs on components and shipping
- 05Our market is very competitive. If we fail to compete successfully, our business and operating results will suffer
- 06Changes in US trade policy, including the imposition of tariffs and the resulting consequences, may have a material adverse impact on our business and results of operations
- 07Economic conditions may adversely impact our business, operating results and financial condition
- 08Changes in our product mix could cause our overall gross margin to decline, which may adversely affect our operating results and financial condition
- 09Our products must meet exact technical and quality specifications. Defects, errors in or interoperability issues with our products or the failure of our products to operate as expected could affect our reputation, result in significant costs to us and impair our ability to sell our products
- 10We may be required to indemnify our customers against liabilities arising from defects in our products or their solutions which incorporate our products. These liabilities may also include costs incurred by our customers or end users to correct the problems or replace our products
- 11We may face claims of intellectual property infringement, which could be time consuming, costly to defend or settle and result in the loss of significant rights
- 12We may incur substantial costs enforcing or acquiring intellectual property rights and defending against third-party claims as a result of litigation or other proceedings
- 13If we are unable to obtain patent protection for our products or otherwise protect our intellectual property rights, our business could suffer
- 14We are subject to order and shipment uncertainties. Inaccuracies in our estimates of customer demand and product mix could negatively affect our inventory levels, sales and operating results
- 15Our sales and marketing efforts may be unsuccessful in maintaining and expanding existing sales channels, developing new sales channels and increasing the sales of our products
- 16Our business would be adversely affected by the departure of members of our executive management team
- 17If we are unable to attract, train and retain qualified personnel, especially our design and technical personnel, we may not be able to effectively execute our business strategy
- 18We have material weaknesses in our internal accounting control over financial reporting and failure to remediate a material weakness in internal accounting controls could result in material misstatements in our financial statements
- 19If we fail to implement proper and effective internal controls, our ability to produce accurate financial statements would be impaired, which could adversely affect our operating results, our ability to operate our business and our stock price
- 20We may need to raise additional capital, which may not be available on favorable terms, if at all, and which may cause dilution to holders of our common stock, restrict our operations or adversely affect our ability to operate our business
- 21Breaches of network or information technology security, natural disasters or terrorist attacks could have an adverse effect on our business
- 22The unfavorable outcome of any future litigation or administrative action could negatively impact us
- 23Non-compliance with, or changes in, the legal and regulatory environment in the countries in which we operate could increase our costs or reduce our net operating revenues
- 24Acquisitions may expose us to additional risks
- 25We and/or certain of our current and former officers and directors, may face litigation and legal proceedings which could adversely affect our business, financial condition, results of operations or cash flows
Risks Relating to our Common Stock and our Listed Warrants
- 26If our business developments and achievements do not meet the expectations of investors or securities analysts or for other reasons the expected benefits do not occur, the market price of shares of our Common Stock traded on Nasdaq may decline
- 27The price of shares of our Common Stock has fluctuated substantially. Therefore, some investors who have purchased our Common Stock at high prices face the risk of losing a significant portion of their original investment if they have to sell at a time when the price of shares of our Common Stock has declined
- 28Future sales or perceived sales of our common stock could depress our stock price
- 29Our common stock may be affected by limited trading volume and price fluctuations, which could adversely impact the value of our common stock
- 30Provisions in our articles of incorporation and bylaws could discourage a change in control, or an acquisition of us by a third party, even if the acquisition would be favorable to you, thereby adversely affecting existing shareholders
- 31The ability of Fawad Maqbool, our Chairman, to sell his stake in us and speculation about any such sale may adversely affect the market price of our common stock
- 32Because Fawad Maqbool, our Chairman controls a significant number of shares of our voting capital stock, he has the ability to influence actions requiring stockholder approval
- 33Because we do not intend to pay cash dividends on our shares of common stock, any returns will be limited to the value of our shares
- 34You may experience future dilution as a result of future equity offerings and other issuances of our common stock or other securities. In addition, future equity offerings and other issuances of our common stock or other securities may adversely affect our common stock price
- 35There can be no assurance that we will be able to comply with the continued listing standards of the Nasdaq Capital Market, a failure which could result in the de-listing of our common stock
- 36The Listed Warrants are speculative in nature
- 37Holders of the Listed Warrants will have no rights as common stockholders until they acquire our common stock
- 38Provisions of the Listed Warrants could discourage an acquisition of us by a third party
Other AmpliTech Group 10-Ks
- FY2025 10-K risk factors44 risks8 new2 dropped9 reworded
Customer concentration intensified with one client accounting for 42.86% of 2025 sales compared to 13.97% in 2024. Accumulated deficit expanded to $28.02 million after recording a $7.01 million net loss in 2025. Multiple new risks were added regarding the speculative nature, expiration dates, and irrevocability of Series A and B Rights offerings.
Filed Mar 26, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.